Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
3.202 EUR | -1.48% |
|
+3.16% | -32.16% |
06-26 | Valneva SE Appoints Daniele Guyot-Caparros as Board of Directors | CI |
06-24 | Valneva's Chikungunya Vaccine Receives Health Canada's Approval | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.16% | 484M | |
+21.85% | 46.44B | |
+38.65% | 39.1B | |
-8.05% | 38.76B | |
+29.04% | 31.24B | |
-13.75% | 25.8B | |
+10.65% | 25.9B | |
+38.43% | 13.12B | |
-6.92% | 11.32B | |
-12.29% | 10.68B |
- Stock Market
- Equities
- VLA Stock
- News Valneva
- Valneva Secures Canadian Approval for Chikungunya Vaccine